Galmed Pharmaceuticals Lt... (GLMD)

NasdaqCM: GLMD · 실시간 가격 · USD

0.52

-0.01 (-1.89%)

종가 기준: Aug 14, 2026, 8:00 PM

0.49

-7.23%

애프터마켓: 7:57 PM

-1.89% (1D)

데이터 없음

매수호가	n/a
시가총액	4.32M
매출 (ttm)	n/a
순이익 (ttm)	-11.12M
베타	0.68
EPS (ttm)	-2.06
P/E (ttm)	n/a
선행 P/E	-0.51
P/B (ttm)	0.25
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	n/a
거래량	33,409
평균 거래량 (20일)	754,529
시가	0.52
전일 종가	0.53
일중 범위	0.51 - 0.53
52주 범위	0.41 - 1.65
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

GLMD 소개

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The comp...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Mar 13, 2014

직원 수 3

상장 거래소 NasdaqCM

티커 GLMD

웹사이트 https://galmedpharma.com

전체 기업 정보

재무 실적

2025년 Galmed Pharmaceuticals의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -10.31M로, 37.14% 증가했습니다.

재무제표

어닝 서프라이즈

Galmed Pharmaceuticals가 Jul 8, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -0.29 예상치 상회 0.09, 및 53.23% 전년 대비 성장.

뉴스

1개월 전 · InvestorsHub

Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline (NASDAQ:GLMD)

Galmed announced the development of a lipid nanoparticle formulation of Aramchol designed to target heart tissue, marking a potential expansion of the drug beyond its existing liver and gastrointestin...

8개월 전 · Associated Press Finance

Galmed Pharmaceuticals: Q3 Earnings Snapshot

RAMAT GAN, Israel (AP) — Galmed Pharmaceuticals Ltd. (GLMD) on Wednesday reported a loss of $1.9 million in its third quarter. The Ramat Gan, Israel-based company said it had a loss of 33 cents per sh...

9개월 전 · Associated Press Finance

BC-Most Active Stocks

HIVE Digital Technologies Ltd. 30,450,329 3.7899

11개월 전 · Associated Press Finance

Galmed Pharmaceuticals: Q2 Earnings Snapshot

RAMAT GAN, Israel (AP) — Galmed Pharmaceuticals Ltd. (GLMD) on Thursday reported net income of $2.5 million in its second quarter. On a per-share basis, the Ramat Gan, Israel-based company said it had...